Testing TL-925 eye drops for allergic conjunctivitis
Part of Eyes & vision, Immune system & allergy clinical trials.
This trial tests an investigational eye drop called TL-925 to see if it can treat allergic conjunctivitis (eye allergies). If you have a history of eye allergies and a positive allergy skin test, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have a history of eye allergies and a positive skin test to a common allergen like grass, ragweed, pet dander, or dust mites
- You must not have any other eye disease or infection that could affect the results
- You must not have had eye surgery in the last 3 months or laser eye surgery in the last 6 months
- If you could become pregnant, you and your partner must use highly effective birth control during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational eye drop called TL-925 for people with seasonal allergic conjunctivitis (eye allergies triggered by pollen, grass, etc.). It aims to see if TL-925 can relieve symptoms like redness and itching.
This trial studies whether vitamin D affects the surface of the eye, the eye’s normal germs, eye inflammation, and vision in children with allergic conjunctivitis. If vitamin D helps, it could improve symptoms and eye comfort.
This trial tests a new antibody treatment for eye allergy symptoms caused by birch pollen. It may help if you have severe eye allergies during birch season.
This trial tests an injectable treatment that may help manage eye allergy symptoms caused by cat allergies. It aims to see if the treatment is safe and effective for adults and children, and includes a controlled cat exposure challenge.
This study tests a new medication called DFL24498 for people with atopic keratoconjunctivitis (AKC), a severe allergic eye condition. The goal is to see if it reduces itching, discomfort, and eye redness safely.
This study tests whether RCI001, a new eye drop treatment, can help people with dry eye disease. If you've had dry eye symptoms for at least 6 months and are interested in trying a new treatment, this trial may be for you.
Hear when a new Allergic Conjunctivitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.